HSP90 alpha/beta Antibody (F-8)

Santa Cruz Biotechnology, Inc. was awarded contract A207_PO-0489076 by the University of Virginia on October 7, 2026, with a cumulative contract value of $312. The specific products or services to be delivered under this purchase order are not detailed in the available documentation. Based on the awardee's business operations, the contract likely involves the provision of research reagents, antibodies, or related biotechnology products; however, the exact scope of work cannot be definitively determined from the information provided.

The contracting organization, University of Virginia, is located in Virginia. No additional details regarding the period of performance, specific place of performance, or itemized annual value are available in the contract award documentation. The minimal contract value suggests this represents a purchase order for limited quantities of materials or services rather than a comprehensive research or service delivery agreement.